BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 18347879)

  • 21. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.
    Maire F; Hammel P; Terris B; Paye F; Scoazec JY; Cellier C; Barthet M; O'Toole D; Rufat P; Partensky C; Cuillerier E; Lévy P; Belghiti J; Ruszniewski P
    Gut; 2002 Nov; 51(5):717-22. PubMed ID: 12377813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma in the Netherlands: A Nationwide Retrospective Analysis.
    de Rooij T; Tol JA; van Eijck CH; Boerma D; Bonsing BA; Bosscha K; van Dam RM; Dijkgraaf MG; Gerhards MF; van Goor H; van der Harst E; de Hingh IH; Kazemier G; Klaase JM; Molenaar IQ; Patijn GA; van Santvoort HC; Scheepers JJ; van der Schelling GP; Sieders E; Busch OR; Besselink MG;
    Ann Surg Oncol; 2016 Feb; 23(2):585-91. PubMed ID: 26508153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distal pancreatectomy with celiac axis resection for carcinoma of the body and tail of the pancreas.
    Takahashi Y; Kaneoka Y; Maeda A; Isogai M
    World J Surg; 2011 Nov; 35(11):2535-42. PubMed ID: 21901326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The differential effects of sarcopenia and cachexia on overall survival for pancreatic ductal adenocarcinoma patients following pancreatectomy: A retrospective study based on a large population.
    Shen XD; Wang X; Zheng ZJ; Chen YH; Tan CL; Liu XB; Ke NW
    Cancer Med; 2023 May; 12(9):10438-10448. PubMed ID: 36938648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Impact of Tumor Location on Resection and Survival for Pancreatic Ductal Adenocarcinoma.
    Winer LK; Dhar VK; Wima K; Morris MC; Lee TC; Shah SA; Ahmad SA; Patel SH
    J Surg Res; 2019 Jul; 239():60-66. PubMed ID: 30802706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteopenia is associated with wasting in pancreatic adenocarcinoma and predicts survival after surgery.
    Cameron ME; Underwood PW; Williams IE; George TJ; Judge SM; Yarrow JF; Trevino JG; Judge AR
    Cancer Med; 2022 Jan; 11(1):50-60. PubMed ID: 34791809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.
    Riediger H; Keck T; Wellner U; zur Hausen A; Adam U; Hopt UT; Makowiec F
    J Gastrointest Surg; 2009 Jul; 13(7):1337-44. PubMed ID: 19418101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defining postoperative weight change after pancreatectomy: Factors associated with distinct and dynamic weight trajectories.
    Trudeau MT; Casciani F; Gershuni VM; Maggino L; Ecker BL; Lee MK; Roses RE; DeMatteo RP; Fraker DL; Drebin JA; Vollmer CM
    Surgery; 2020 Dec; 168(6):1041-1047. PubMed ID: 32943201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis of factors influencing recurrence and metastasis following curative resection of pancreatic ductal adenocarcinoma].
    Xie YB; Zhao P; Wang CF; Shan Y; Zhao DB; Liu Q; Bai XF
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):686-9. PubMed ID: 19173911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer.
    Hartwig W; Gluth A; Hinz U; Koliogiannis D; Strobel O; Hackert T; Werner J; Büchler MW
    Br J Surg; 2016 Nov; 103(12):1683-1694. PubMed ID: 27686238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
    Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
    Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of adjacent organ resection in patients with left-sided pancreatic ductal adenocarcinoma following distal pancreatectomy.
    Song KB; Kwon J; Kim YW; Hwang DW; Lee JH; Hong S; Lee JW; Hwang K; Yoo D; Kim SC
    J Hepatobiliary Pancreat Sci; 2019 Jun; 26(6):227-234. PubMed ID: 30980486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case-control study.
    Gao H; Liu T; Wang G; Gao Y; Yin L; Peng Y; Lyu N; Zhang K; Gao W; Wu J; Jiang K; Wei J; Miao Y
    Langenbecks Arch Surg; 2019 Mar; 404(2):175-182. PubMed ID: 30826926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas.
    Åkerberg D; Ansari D; Andersson R
    World J Gastroenterol; 2016 Jul; 22(28):6424-33. PubMed ID: 27605878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile?
    Crippa S; Partelli S; Zamboni G; Barugola G; Capelli P; Inama M; Bassi C; Pederzoli P; Falconi M
    Surgery; 2012 Sep; 152(3 Suppl 1):S112-9. PubMed ID: 22766365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oligometastatic pulmonary metastasis in pancreatic cancer patients: Safety and outcome of resection.
    Ilmer M; Schiergens TS; Renz BW; Schneider C; Sargut M; Waligora R; Weniger M; Hartwig W; Ceyhan GO; Friess H; Werner J; D'Haese JG
    Surg Oncol; 2019 Dec; 31():16-21. PubMed ID: 31473583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distal pancreatectomy for resectable adenocarcinoma of the body and tail of the pancreas.
    Christein JD; Kendrick ML; Iqbal CW; Nagorney DM; Farnell MB
    J Gastrointest Surg; 2005; 9(7):922-7. PubMed ID: 16137585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study.
    Labori KJ; Katz MH; Tzeng CW; Bjørnbeth BA; Cvancarova M; Edwin B; Kure EH; Eide TJ; Dueland S; Buanes T; Gladhaug IP
    Acta Oncol; 2016; 55(3):265-77. PubMed ID: 26213211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical presentation and prognosis of adenosquamous carcinoma of the pancreas - Matched-pair analysis with pancreatic ductal adenocarcinoma.
    Kaiser J; Hinz U; Mayer P; Hank T; Niesen W; Hackert T; Gaida MM; Büchler MW; Strobel O
    Eur J Surg Oncol; 2021 Jul; 47(7):1734-1741. PubMed ID: 33622577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: a retrospective, single-institution experience.
    Takai S; Satoi S; Toyokawa H; Yanagimoto H; Sugimoto N; Tsuji K; Araki H; Matsui Y; Imamura A; Kwon AH; Kamiyama Y
    Pancreas; 2003 Apr; 26(3):243-9. PubMed ID: 12657950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.